Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy
Authors:
- 18 October 2022
- journal article
- editorial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 76 (5) , 930-933
Abstract
We found that urine tenofovir (TFV) levels >1500 ng/mL strongly predict virologic suppression among people with human immunodeficiency virus taking tenofovir alafenamide (odds ratio, 5.66; 95% confidence interval, 1.59–20.14; P = .007). This suggests an existing point-of-care assay developed for tenofovir disoproxil fumarate will support adherence monitoring for patients on all TFV-based antiretrovirals.Keywords
Funding Information
- National Institute of Mental Health (K23MH122286)
- National Institute of Allergy and Infectious Diseases (R01AI152119)
- National Institutes of Health
This publication has 10 references indexed in Scilit:
- HIV Treatment Outcomes in POP-UP: Drop-in HIV Primary Care Model for People Experiencing HomelessnessThe Journal of Infectious Diseases, 2022
- Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited SettingsAIDS Research and Human Retroviruses, 2022
- Brief Report: No Difference in Urine Tenofovir Levels in Patients Living With HIV on Unboosted Versus Dose-Adjusted Boosted Tenofovir AlafenamideJAIDS Journal of Acquired Immune Deficiency Syndromes, 2021
- Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care TestingOpen Forum Infectious Diseases, 2021
- Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir AlafenamideFrontiers in Pharmacology, 2020
- Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care TestJAIDS Journal of Acquired Immune Deficiency Syndromes, 2019
- Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration projectAIDS, 2019
- Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral AdherenceeClinicalMedicine, 2018
- Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV SuppressionClinical Infectious Diseases, 2016
- Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2015